Navigation Links
Clinical Site Services' Chris Trizna Contributing Author in Diana Anderson-Foster's Newest Release 'Global Issues in Patient Recruitment and Retention'
Date:7/17/2012

GLEN BURNIE, Md., July 17, 2012 /PRNewswire/ -- Chris Trizna, President of Clinical Site Services (CSS), a Maryland company focused on optimizing and accelerating the trial enrollment process for sponsor companies, CROs and investigative sites, is included as a contributing author in Diana Anderson-Foster's newest book, "Global Issues in Patient Recruitment and Retention," published in June 2012 by CenterWatch.

It is well-documented that slow patient enrollment is a global contributor of study delays. Likewise, retaining patients once enrolled can be equally arduous, but just as critical to the completion and success of a clinical trial. In her second book on the subject, industry expert Diana Anderson-Foster tackles for the first time the global challenges posed by these everyday issues and provides thoughtful analysis and strategic solutions to minimize recruitment costs and develop successful global patient recruitment programs. With insight and contributions from thought-leaders in the industry, this guide also delves into the sponsor's perspective on patient recruitment and tackles new emerging topics including technology challenges, phase I recruiting and the role of social media.

"It was a honor to be able to contribute to this book," shared Trizna. "As individuals in the pharmaceutical industry are finding out, global planning for recruitment and retention is a very complex process. Diana's book provides a thorough breakdown of how to approach and find success where global trials are involved."

"Working with global clinical trials requires more than simply providing translation services for each country's recruitment materials," added Trizna. "There is a complex strategy to everything, and it begins with careful planning, research and budgeting."

For more information about "Global Issues in Patient Recruitment and Retention," please visit https://store.centerwatch.com/p-311-global-issues-in-patient-recruitment-and-retention.aspx.

For quantity book orders, please direct the inquiries to sales@centerwatch.com.

About Clinical Site Services

Clinical Site Services (CSS) is a site performance company that provides solutions to increase the enrollment potential for investigative sites. Through a proprietary, integrated process, CSS strives to reduce the costs and timelines associated with recruitment subjects for clinical studies.

For More Information

Visit www.ClinicalSiteServices.com, or contact Jennifer Whitlock, Vice President, at jwhitlock@clinicalsiteservices.com or 443-308-5803.

Contact:

Jennifer Whitlock
Clinical Site Services
P: 443-308-5803
F: 410-553-0087
jwhitlock@clinicalsiteservices.com
www.clinicalsiteservices.com

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Clinical Site Services
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. ERT Granted Patents on Clinical Trial Participant Compliance
2. Life Technologies to Accelerate Development of Ion Torrent Semiconductor Technology for Proteomic Applications in Research, Applied and Clinical Markets
3. Healthcare Cloud Computing (Clinical, EMR, SaaS, Private, Public, Hybrid) Market - Global Trends, Challenges, Opportunities & Forecasts (2012 - 2017)
4. Beyond Batten Disease Foundation and American Brain Foundation Launch First Clinical Research Fellowship to Treat and Cure Juvenile Batten Disease
5. Frost & Sullivan Presents 2012 Clinical Diagnostics Company of the Year Award to GenPath Diagnostics of BioReference Laboratories, Inc.
6. Access Pharmaceuticals to Report New MuGard Clinical Trial Data This Week at the MASCC/ISOO Symposium in New York City
7. Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
8. Agility Clinical, Inc., a Specialty Contract Research Organization is Formed
9. Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy
10. MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models
11. OrbusNeichs Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/23/2016)... ... 2016 , ... UAS LifeSciences, one of the leading manufacturers ... Probiotics, into Target stores nationwide. The company, which has been manufacturing high quality ... list of well-respected retailers. This list includes such fine stores as Whole Foods, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
Breaking Biology Technology:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
Breaking Biology News(10 mins):